63 related articles for article (PubMed ID: 10520009)
1. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Pagano L; Pulsoni A; Tosti ME; Annino L; Mele A; Camera A; Martino B; Guglielmi C; Cerri R; Di Bona E; Invernizzi R; Castagnola C; Bassan R; Mele L; Todeschini G; Leone G; Mandelli F
Br J Haematol; 1999 Sep; 106(4):1037-40. PubMed ID: 10520009
[TBL] [Abstract][Full Text] [Related]
2. 'Secondary' acute lymphoblastic/lymphocytic leukemia - done playing second fiddle?
Riazat-Kesh YJRA; Mascarenhas J; Bar-Natan M
Blood Rev; 2023 Jul; 60():101070. PubMed ID: 36894417
[TBL] [Abstract][Full Text] [Related]
3. Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic.
Borkhardt A; Schüz J; Trübenbach C; Wellbrock M; Spix C; Erdmann F
Leukemia; 2022 Dec; 36(12):2908-2911. PubMed ID: 36289349
[No Abstract] [Full Text] [Related]
4. MN1::ETV6-positive de novo T-cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report.
Zhang X; Zhong Y; Liu L; Suo S; Zhao S; Xiao F; Qin J; Tong H; Jin J; Yu W
Br J Haematol; 2024 Apr; ():. PubMed ID: 38685592
[No Abstract] [Full Text] [Related]
5. Secondary or Symptomatic Leukæmia.
Ward GR
Proc R Soc Med; 1914; 7(Med Sect):126-58. PubMed ID: 19977944
[No Abstract] [Full Text] [Related]
6. Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis.
Abdulwahab A; Sykes J; Kamel-Reid S; Chang H; Brandwein JM
Cancer; 2012 Aug; 118(16):3962-7. PubMed ID: 22180297
[TBL] [Abstract][Full Text] [Related]
7. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
[TBL] [Abstract][Full Text] [Related]
8. A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine.
Hu M; Li W; Li P; Tan J; Wang Y
Front Oncol; 2024; 14():1329279. PubMed ID: 38737911
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registry.
Sadowska-Klasa A; Zaucha JM; Labopin M; Bourhis JH; Blaise D; Yakoub-Agha I; Salmenniemi U; Passweg J; Fegueux N; Schroeder T; Giebel S; Brissot E; Ciceri F; Mohty M
Bone Marrow Transplant; 2024 Mar; 59(3):387-394. PubMed ID: 38195982
[TBL] [Abstract][Full Text] [Related]
10. A novel preclinical model of mucopolysaccharidosis type II for developing human hematopoietic stem cell gene therapy.
Shimada Y; Ishii N; Higuchi T; Goto M; Ohashi T; Kobayashi H
Gene Ther; 2023 Apr; 30(3-4):288-296. PubMed ID: 35835952
[TBL] [Abstract][Full Text] [Related]
11. Lenalidomide induced secondary Acute Lymphoblastic Leukemia in a Multiple Myeloma patient: A case-report.
Khan DSR; Tariq DM; Fayyaz DSM; Soomar SM; Moosajee DM
Leuk Res Rep; 2022; 17():100315. PubMed ID: 35462726
[TBL] [Abstract][Full Text] [Related]
12. Synchronous B-Cell Acute Lymphoblastic Leukemia and Serous Ovarian Carcinoma: A Case Report.
Superdock M; Komisarof J; Katerji H; Huselton E
Case Rep Oncol; 2021; 14(3):1621-1626. PubMed ID: 34950006
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia.
Vasudevan Nampoothiri R; Viswabandya A
Indian J Hematol Blood Transfus; 2021 Oct; 37(4):521-527. PubMed ID: 34744336
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease.
Demirci S; Leonard A; Essawi K; Tisdale JF
Mol Ther Methods Clin Dev; 2021 Dec; 23():276-285. PubMed ID: 34729375
[TBL] [Abstract][Full Text] [Related]
15. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.
Hsieh MM; Bonner M; Pierciey FJ; Uchida N; Rottman J; Demopoulos L; Schmidt M; Kanter J; Walters MC; Thompson AA; Asmal M; Tisdale JF
Blood Adv; 2020 May; 4(9):2058-2063. PubMed ID: 32396618
[TBL] [Abstract][Full Text] [Related]
17. B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma.
Gaut D; Bejjani A; Sasine J; Schiller G
Hematol Rep; 2019 May; 11(2):8100. PubMed ID: 31285810
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
19. Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report.
Burgos S; Montalban-Bravo G; Fuente L; Jabbour EJ; Kanagal-Shamanna R; Soltysiak KA; Garcia-Manero G; Mela-Osorio MJ
Medicine (Baltimore); 2019 Jan; 98(1):e14011. PubMed ID: 30608448
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related acute lymphoblastic leukemia.
Ribera JM
Haematologica; 2018 Oct; 103(10):1581-1583. PubMed ID: 30270204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
